Recovery is best supported through structured, evidence based care
Detailed Product Description The BPC-157 + TB-500 peptide blend combines two investigational agents with complementary regenerative actions
Clinical Applications While human trials are limited and 5-Amino-1MQ is not FDA-approved as a therapeutic agent, its mechanism and early research suggest potential benefits in: Weight management and body recomposition Adiposity reduction and fat loss Insulin sensitivity improvement Metabolic syndrome support NAD optimization and anti-aging protocols Cellular energy and endurance enhancement Adjunct to exercise or caloric restriction protocols It may be particularly relevant for individuals with stubborn fat loss resistance , age-related metabolic decline, or those using NAD-supportive therapies like NMN or NR
For extended storage, aliquot and freeze at -20C
To maintain your results, your provider will craft a long-term plan, which may consist of healthy lifestyle changes and ongoing, but less frequent, peptide therapy
Deckel A, Duffy J (2000) Vasomotor hyporeactivity in the anterior cerebral artery during motor activation in Huntingtons disease patients
.png.jpg)
